Quantification of IgG monoclonal antibody clearance in tissues

References

• Datta-Mannan A, Lu J, Witcher DR, Leung D, Tang Y, Wroblewski VJ. The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies. MAbs 2015; 7(6):1084-93; PMID:26337808; https://doi.org/10.1080/19420862.2015.107519
   PubMed Web of Science ®Google Scholar
• Wohlrab J. Pharmacokinetic characteristics of therapeutic antibodies. J Dtsch Dermatol Ges 2015; 13(6):530-4; PMID:26018364; https://doi.org/10.1111/ddg.12648
   PubMed Web of Science ®Google Scholar
• Diao L, Meibohm B. Tools for predicting the PK/PD of therapeutic proteins. Expert Opin Drug Metab Toxicol 2015; 11(7):1115-25; PMID:25936400; https://doi.org/10.1517/17425255.2015.1041917
   PubMed Web of Science ®Google Scholar
• Waldmann TA, Strober W. Metabolism of immunoglobulins. Prog Allergy 1969; 13:1-110; PMID:4186070
   PubMedGoogle Scholar
• Ward ES, Zhou J, Ghetie V, Ober RJ. Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans. Int Immunol 2003; 15(2):187-95; PMID:12578848; https://doi.org/10.1093/intimm/dxg018
   PubMed Web of Science ®Google Scholar
• Montoyo HP, Vaccaro C, Hafner M, Ober RJ, Mueller W, Ward ES. Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice. Proc Natl Acad Sci U S A 2009; 106(8):2788-93; PMID:19188594; https://doi.org/10.1073/pnas.0810796106
   PubMed Web of Science ®Google Scholar
• Rath T, Baker K, Dumont JA, Peters RT, Jiang H, Qiao SW, Lencer WI, Pierce GF, Blumberg RS. Fc-fusion proteins and FcRn: Structural insights for longer-lasting and more effective therapeutics. Crit Rev Biotechnol 2015; 35(2):235-54; PMID:24156398; https://doi.org/10.3109/07388551.2013.834293
   PubMed Web of Science ®Google Scholar
• Borvak J, Richardson J, Medesan C, Antohe F, Radu C, Simionescu M, Ghetie V, Ward ES. Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. Int Immunol 1998; 10(9):1289-98; PMID:9786428; https://doi.org/10.1093/intimm/10.9.1289
   PubMed Web of Science ®Google Scholar
• Akilesh S, Christianson GJ, Roopenian DC, Shaw AS. Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 2007; 179(7):4580-8; PMID:17878355; https://doi.org/10.4049/jimmunol.179.7.4580
   PubMed Web of Science ®Google Scholar
• Ober RJ, Martinez C, Lai X, Zhou J, Ward ES. Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level. Proc Natl Acad Sci U S A 2004; 101(30):11076-81; PMID:15258288; https://doi.org/10.1073/pnas.0402970101
   PubMed Web of Science ®Google Scholar
• Tzaban S, Massol RH, Yen E, Hamman W, Frank SR, Lapierre LA, Hansen SH, Goldenring JR, Blumberg RS, Lencer WI. The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity. J Cell Biol 2009; 185(4):673-84; PMID:19451275; https://doi.org/10.1083/jcb.200809122
   PubMed Web of Science ®Google Scholar
• Gan Z, Ram S, Vaccaro C, Ober RJ, Ward ES. Analyses of the recycling receptor, FcRn, in live cells reveal novel pathways for lysosomal delivery. Traffic 2009; 10(5):600-14; PMID:19192244; https://doi.org/10.1111/j.1600-0854.2009.00887.x
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Akilesh S. FcRn: The neonatal Fc receptor comes of age. Nat Rev Immunol 2007; 7(9):715-25; PMID:17703228; https://doi.org/10.1038/nri2155
   PubMed Web of Science ®Google Scholar
• Ober RJ, Martinez C, Vaccaro C, Zhou J, Ward ES. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J Immunol 2004; 172(4):2021-9; PMID:14764666; https://doi.org/10.4049/jimmunol.172.4.2021
   PubMed Web of Science ®Google Scholar
• Ghetie V, Hubbard JG, Kim JK, Tsen MF, Lee Y, Ward ES. Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol 1996; 26(3):690-6; PMID:8605939; https://doi.org/10.1002/eji.1830260327
   PubMed Web of Science ®Google Scholar
• Chaudhury C, Mehnaz S, Robinson JM, Hayton WL, Pearl DK, Roopenian DC, Anderson CL. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 2003; 197(3):315-22; PMID:12566415; https://doi.org/10.1084/jem.20021829
   PubMed Web of Science ®Google Scholar
• Chen N, Wang W, Fauty S, Fang Y, Hamuro L, Hussain A, Prueksaritanont T. The effect of the neonatal Fc receptor on human IgG biodistribution in mice. MAbs 2014; 6(2):502-8; PMID:24492305; https://doi.org/10.4161/mabs.27765
   PubMed Web of Science ®Google Scholar
• Henderson LA, Baynes JW, Thorpe SR. Identification of the sites of IgG catabolism in the rat. Arch Biochem Biophys 1982; 215(1):1-11; PMID:7092219; https://doi.org/10.1016/0003-9861(82)90272-7
   PubMed Web of Science ®Google Scholar
• Wright A, Sato Y, Okada T, Chang K, Endo T, Morrison S. In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure. Glycobiology 2000; 10(12):1347-55; PMID:11159927; https://doi.org/10.1093/glycob/10.12.1347
   PubMed Web of Science ®Google Scholar
• Yip V, Palma E, Tesar DB, Mundo EE, Bumbaca D, Torres EK, Reyes NA, Shen BQ, Fielder PJ, Prabhu S, et al. Quantitative cumulative biodistribution of antibodies in mice: Effect of modulating binding affinity to the neonatal Fc receptor. MAbs 2014; 6(3):689-96; PMID:24572100; https://doi.org/10.4161/mabs.28254
   PubMed Web of Science ®Google Scholar
• Ferl GZ, Kenanova V, Wu AM, DiStefano JJ, 3rd. A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments. Mol Cancer Ther 2006; 5(6):1550-8; PMID:16818514; https://doi.org/10.1158/1535-7163.MCT-06-0072
   PubMed Web of Science ®Google Scholar
• Press OW, Shan D, Howell-Clark J, Eary J, Appelbaum FR, Matthews D, King DJ, Haines AM, Hamann P, Hinman L, et al. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res 1996; 56(9):2123-9; PMID:8616860
   PubMed Web of Science ®Google Scholar
• Tsai SW, Li L, Williams LE, Anderson AL, Raubitschek AA, Shively JE. Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments. Bioconjug Chem 2001; 12(2):264-70; PMID:11312688; https://doi.org/10.1021/bc0000987
   PubMed Web of Science ®Google Scholar
• Rogers BE, Franano FN, Duncan JR, Edwards WB, Anderson CJ, Connett JM, Welch MJ. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. Cancer Res 1995; 55(23 Suppl):5714s-20s; PMID:7493333
   PubMed Web of Science ®Google Scholar
• Ferl GZ, Wu AM, DiStefano JJ, 3rd. A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal Fc receptor (FcRn). Ann Biomed Eng 2005; 33(11):1640-52; PMID:16341929; https://doi.org/10.1007/s10439-005-7410-3
   PubMed Web of Science ®Google Scholar
• Garg A, Balthasar JP. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn 2007; 34(5):687-709; PMID:17636457; https://doi.org/10.1007/s10928-007-9065-1
   PubMed Web of Science ®Google Scholar
• Urva SR, Yang VC, Balthasar JP. Physiologically based pharmacokinetic model for T84.66: A monoclonal anti-CEA antibody. J Pharm Sci 2010; 99(3):1582-600; PMID:19774657; https://doi.org/10.1002/jps.21918
   PubMed Web of Science ®Google Scholar
• Baxter LT, Zhu H, Mackensen DG, Jain RK. Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res 1994; 54(6):1517-28; PMID:8137258
   PubMed Web of Science ®Google Scholar
• Fan YY, Avery LB, Wang M, O'Hara DM, Leung S, Neubert H. Tissue expression profile of human neonatal Fc receptor (FcRn) in Tg32 transgenic mice. MAbs 2016; 8(5):848-53; PMID:27104806; https://doi.org/10.1080/19420862.2016.1178436
   PubMed Web of Science ®Google Scholar
• Chen Y, Balthasar JP. Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn. Aaps J 2012; 14(4):850-9; PMID:22956476; https://doi.org/10.1208/s12248-012-9395-9
   PubMed Web of Science ®Google Scholar
• Deng Y, Lei M, Zhang W, Li W, Zhou E, Liu Z, Qi C. Monoclonal antibodies directed against Fpr3 protein as molecular chaperones. Hybridoma (Larchmt) 2011; 30(5):491-3; PMID:22008079; https://doi.org/10.1089/hyb.2011.0053
   PubMedGoogle Scholar
• Shah DK, Betts AM. Antibody biodistribution coefficients: Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human. MAbs 2013; 5(2):297-305; PMID:23406896; https://doi.org/10.4161/mabs.23684
   PubMed Web of Science ®Google Scholar
• Rippe B, Haraldsson B. Transport of macromolecules across microvascular walls: The two-pore theory. Physiol Rev 1994; 74(1):163-219; PMID:8295933
   PubMed Web of Science ®Google Scholar
• Shah DK, Betts AM. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn 2012; 39(1):67-86; PMID:22143261; https://doi.org/10.1007/s10928-011-9232-2
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993; 10(7):1093-5; PMID:8378254; https://doi.org/10.1023/A:1018943613122
   PubMed Web of Science ®Google Scholar
• Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 1997; 13(4):407-84; PMID:9249929; https://doi.org/10.1177/074823379701300401
   PubMed Web of Science ®Google Scholar